Korro Bio, Inc. Annual Income Tax Expense (Benefit) in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Korro Bio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2024.
  • Korro Bio, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $103K.
  • Korro Bio, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $141K, a 422% increase year-over-year.
  • Korro Bio, Inc. annual Income Tax Expense (Benefit) for 2024 was $141K, a 422% increase from 2023.
  • Korro Bio, Inc. annual Income Tax Expense (Benefit) for 2023 was $27K, a 170% increase from 2022.
  • Korro Bio, Inc. annual Income Tax Expense (Benefit) for 2022 was $10K, a 33.3% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $141K +$114K +422% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-18
2023 $27K +$17K +170% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-18
2022 $10K -$5K -33.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $15K -$20K -57.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $35K +$35K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.